Synmosa Biopharma Correlations
| 4114 Stock | TWD 34.30 0.25 0.73% |
The current 90-days correlation between Synmosa Biopharma and Alar Pharmaceuticals is 0.33 (i.e., Weak diversification). The correlation of Synmosa Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Synmosa Biopharma Correlation With Market
Average diversification
The correlation between Synmosa Biopharma and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Synmosa Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Synmosa |
The ability to find closely correlated positions to Synmosa Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Synmosa Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Synmosa Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Synmosa Biopharma to buy it.
Moving together with Synmosa Stock
| 0.85 | 6620 | Handa Pharmaceuticals | PairCorr |
| 0.65 | 6539 | DV Biomed | PairCorr |
| 0.87 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.76 | 2891C | CTBC Financial Holding | PairCorr |
| 0.61 | 2888 | Shin Kong Financial | PairCorr |
Moving against Synmosa Stock
| 0.85 | 2881A | Fubon Financial Holding | PairCorr |
| 0.82 | 2891 | CTBC Financial Holding | PairCorr |
| 0.8 | 2891B | CTBC Financial Holding | PairCorr |
| 0.78 | 2882B | Cathay Financial Holding | PairCorr |
| 0.71 | 4123 | Center Laboratories | PairCorr |
| 0.59 | 2881B | Fubon Financial Holding | PairCorr |
| 0.53 | 2882A | Cathay Financial Holding | PairCorr |
| 0.49 | 2330 | Taiwan Semiconductor | PairCorr |
| 0.49 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.46 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.45 | 1796 | GeneFerm Biotechnology | PairCorr |
| 0.4 | 2882 | Cathay Financial Holding | PairCorr |
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Synmosa Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Synmosa Biopharma Corporate Management
Elected by the shareholders, the Synmosa Biopharma's board of directors comprises two types of representatives: Synmosa Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synmosa. The board's role is to monitor Synmosa Biopharma's management team and ensure that shareholders' interests are well served. Synmosa Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synmosa Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChihHui Lin | GM, Chairman | Profile | |
| Zen Young | Marketing HP | Profile | |
| Hongqin Bai | Sr Officer | Profile | |
| Banson Lin | Sr Distributors | Profile | |
| JiaXin Zhang | VP | Profile | |
| HungChin Pai | VP Officer | Profile |